In 2020, the global orthopaedic trauma devices market is expected to generate $8.5 billion in sales. According to sales projections, the market will be worth US$ 18 billion by 2031, growing at an annual rate of 8% over the next 10 years.
The fastest-growing market is predicted to be orthopaedic trauma devices. According to this industry analysis, the top five market players control roughly 72 percent of the market.
The demand for orthopaedic trauma devices has risen as the number of traffic accidents and trauma cases has increased around the world. The need for implants and prosthetics is increasing by the day, and this trend is projected to continue.
Zimmer Biomet, a leading developer of orthopaedic trauma devices, has teamed up with Bactiguard, a Swedish medical device company that specialises in infection prevention. The Zimmer Natural Nail (ZNN) Bactiguard implants, which are presently accessible in some EMEA markets and will be offered across regions soon, are the result of this cooperative venture.
This new collaboration has cleared the path for a long-term solution to the problem of infection prevention in trauma implants, which has been a major challenge in the past. The cooperation was formed with the goal of offering and developing orthopaedic trauma implants that are more effective at preventing infection and last longer.
The Oscar Pro Ultrasonic Arthroplasty Revision Technology, an ultrasonic surgical system, was officially launched in the United States and Europe by Orthofix Medical. The tool is designed to make it easier to revise failed cemented arthroplasties during complicated joint procedures. This new solution expands functionality and removes some of the limits that come with co-working.
The global orthopaedic trauma devices market, which is expected to reach US$ 9 billion by 2021, is expected to rise steadily. The rise in digital orthopaedics is expected to drive market expansion throughout the forecast period. By the conclusion of the forecast period, 3D printing technology is likely to create profitable prospects in the market.
Because of the restricted movement, the COVID-19 pandemic is expected to stifle market expansion, resulting in a significant drop in admissions for orthopaedic illnesses. With the lockdown lifted, the market is expected to resume its typical pace, with North America continuing to lead the pack with a large portion of the market.
Western Europe is expected to emerge as a prominent region in the worldwide market, providing new growth opportunities for industry participants. To expand their market position, major industry companies are opting for mergers and acquisitions. To keep ahead of the competition, they are developing new items.
DePuy Synthes., Medtronic, Inc., Smith & Nephew and Stryker, Johnson & Johnson Company, and CONMED, Tornier, Inc. are all well-known participants in the global market.
Comments
Post a Comment